Filter
276
Filtered Results: 276
Text search:
biotechnology
Featured
Recommendations
24
New Publications
57
Language
Document type
No document type
128
Studies & Reports
64
Guidelines
35
Manuals
23
Fact sheets
14
Strategic & Response Plan
9
Training Material
2
Situation Updates
1
Countries / Regions
India
40
Global
15
Bangladesh
6
Nepal
5
Rwanda
5
Western and Central Europe
4
South Africa
4
Nigeria
3
Uganda
3
Ethiopia
3
Myanmar / Burma
3
Colombia
2
Kenya
2
Cameroon
2
Syria
2
Zimbabwe
2
Mozambique
2
USA
2
Africa
2
Haiti
2
Asia
2
Tanzania
2
Germany
2
West and Central Africa
2
South–East Asia Region
2
Russia
2
Botswana
2
Thailand
1
Ukraine
1
Ghana
1
Benin
1
Sierra Leone
1
Iran
1
Afghanistan
1
Peru
1
Malawi
1
Philippines
1
Guinea
1
Cambodia
1
Eastern Europe and Central Asia
1
Paraguay
1
East and Southern Africa
1
Argentina
1
Vietnam
1
Brazil
1
Namibia
1
Sudan
1
Angola
1
Libya
1
Zambia
1
Iraq
1
Liberia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
99
Clinical Guidelines
24
Key Resources
16
Pharmacy & Technologies
13
Public Health
8
Women & Child Health
5
Toolboxes
COVID-19
32
Rapid Response
22
AMR
20
TB
19
Planetary Health
17
Pharmacy
14
Social Ethics
10
HIV
9
NTDs
9
Ebola & Marburg
7
Caregiver
6
Mental Health
5
NCDs
5
Health Financing Toolbox
4
Global Health Education
4
Specific Hazards
3
Refugee
3
Conflict
3
Disability
2
Natural Hazards
1
Cholera
1
Malaria
1
Zika
1
Polio
1
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c...
Polymerase Chain Reaction (PCR) has significantly helped in early diagnosis and commencement of specific interventions for diseases control. It also plays a critical role in understanding the disease epidemiology and unraveling the transmission dynamics of the disease. This manual intends to p...
Health Care Facilities (HCFs) are primarily responsible for management of the healthcare waste generated within the facilities, including activities undertaken by them in the community. The health care facilities, while generating the waste are responsible for segregation, collection, in-house trans...
РУКОВОДСТВО ПО БИОЛОГИЧЕСКОЙ БЕЗОПАСНОСТИ ЛАБОРАТОРНЫХ ИССЛЕДОВАНИЙ ПРИ ТУБЕРКУЛЕЗЕ.
Doc. No.: INS/GDL/001-(Annexes)
No publication year indicated.
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)
Recommendations for Diagnosis and Treatment of Nontuberculous Mycobacterioses of the German Central Committee against Tuberculosis and the German Respirator...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
This report, published in conjunction with a summary overview of results of rounds 1–8, is the eighth and final report in a series of laboratory-based evaluations of rapid diagnostic tests (RDTs) for malaria. It provides a comparative measure of their performance in a standardized way to distingu...
July 2016
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
First Revised Edition
March 2000
